LATAM Advanced Wound Care Company Evaluation Report 2025 Solventum, Smith+Nephew, And Cardinal Health Lead With Advanced Medtech, Surgical Solutions, And Supply Chain Leadership

(MENAFN- GlobeNewsWire - Nasdaq) The Latin America (LATAM) Advanced Wound Care Companies Quadrant provides an in-depth analysis of the regional market, spotlighting top players, technological advancements, and industry trends. The 360 Quadrants evaluated over 106 companies, identifying the top 11 as quadrant leaders. This market, essential for managing chronic wounds like diabetic foot ulcers, is expanding, driven by trends like rising diabetes prevalence and aging populations in Brazil, Mexico, and Colombia. However, challenges such as high costs and healthcare disparities hinder widespread adoption. Key players like Solventum, Smith+Nephew, and Cardinal Health lead via innovation and strategic growth.

Dublin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The "LATAM Advanced Wound Care - Company Evaluation Report, 2025" has been added to ResearchAndMarkets.com's offering.
The Latin America (LATAM) advanced wound care Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Latin America (LATAM) advanced wound care. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and industry trends. The analyst's '360 Quadrants' evaluated over 106 companies, of which the Top 11 Latin America (LATAM) advanced wound care Companies were categorized and recognized as quadrant leaders.
The Latin America (LATAM) advanced wound care market encompasses a portfolio of specialized medical products designed for the treatment of complex, chronic, and hard-to-heal wounds. This category moves beyond traditional dressings to include technologies that actively promote healing. Key products are advanced dressings like hydrocolloids, foams, and alginates that maintain a moist wound environment, as well as active therapies such as Negative Pressure Wound Therapy (NPWT), bio-engineered skin substitutes, and Latin America (LATAM) advanced wound careal growth factors. These solutions are vital for managing diabetic ulcers, venous leg ulcers, and pressure sores.
Market growth in the LATAM region is strongly driven by pressing public health trends, most notably the rising prevalence of diabetes and obesity, which has led to a corresponding increase in chronic wounds like diabetic foot ulcers. A growing geriatric population, more prone to such conditions, also contributes to demand. Furthermore, increasing awareness among clinicians of the proven benefits of advanced wound care, coupled with steadily improving healthcare infrastructure and expenditure in major economies like Brazil, Mexico, and Colombia, is expanding patient access to these modern treatment options.
However, the market faces significant regional challenges. The high cost of advanced wound care products remains a substantial barrier to widespread adoption across the economically diverse countries of Latin America, where public healthcare budgets can be constrained. A shortage of healthcare professionals trained in the proper application of these specialized therapies can limit their effectiveness. The complex logistics of distributing medical products across a vast and geographically varied continent also pose a challenge. A continued reliance on lower-cost traditional dressings in some healthcare systems can further slow market penetration.
Key Players:
The key strategies major vendors implement in the Latin America (LATAM) advanced wound care market are partnerships, collaborations, product launches, and product enhancements.
Solventum
Following its 2024 spin-off from 3M, Solventum has emerged as a major independent healthcare leader. The company commands a significant market presence across key segments including Medical Surgical, Dental Solutions, and Health Information Systems. Leveraging deep expertise in material and data science, Solventum offers a vast portfolio of trusted products, from advanced wound care to clinical documentation software. Its strategic focus on solving critical patient needs while driving growth and margin expansion solidifies its position as a well-capitalized, global medtech innovator poised for continued market influence.
Smith+Nephew
Smith+Nephew is a leading global medical technology company with a strong portfolio in Orthopaedics, Sports Medicine, and Advanced Wound Management. The British multinational is renowned for its hip and knee implants, minimally invasive surgical tools, and advanced wound care products. A central element of its strategy is driving the adoption of its CORIT robotic-assisted surgical system, a key differentiator in the orthopaedics market. Through a focus on innovation in its core segments and a strategic plan to improve operational performance, Smith+Nephew is working to accelerate growth and strengthen its competitive position worldwide.
Cardinal Health
Cardinal Health is an essential pillar of the US healthcare system, operating as a leading pharmaceutical distributor and a major manufacturer of medical supplies. The company's vast logistics network ensures the daily delivery of medicines to pharmacies and hospitals across the nation. Strategically, Cardinal Health is focused on enhancing the growth and profitability of its Medical segment, which produces its own brand of surgical and laboratory products. While optimizing its core distribution business, the company is also investing in high-growth areas like specialty pharmaceuticals, solidifying its critical role in the healthcare supply chain.
Key Topics Covered:
1 Introduction
1.1 Market Definition
1.2 Inclusions & Exclusions
1.3 Stakeholders
2 Executive Summary
3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Increasing Incidence of Chronic Conditions Impairing Wound Healing
3.2.1.1.1 Expansion of Geriatric Population and Emergence of Age-Associated Syndromes
3.2.1.1.2 Rising Incidence of Diabetes
3.2.1.1.3 Increasing Cases of Obesity
3.2.1.2 Growing Number of Burn Injuries
3.2.1.3 Rising Trauma Cases and Road Accidents
3.2.2 Restraints
3.2.2.1 High Cost of Advanced Wound Care Products
3.2.2.2 Risks Associated with Advanced Wound Care Products
3.2.3 Opportunities
3.2.3.1 Expansion of Healthcare Infrastructure and Uptake of Advanced Technologies
3.2.3.2 Universal Health Coverage
3.2.4 Challenges
3.2.4.1 Shortage of Skilled Healthcare Professionals
3.2.4.2 Complications Associated with Delayed Diagnosis and Limited Awareness
3.3 Value Chain Analysis
3.3.1 Research & Development (R&D)
3.3.2 Manufacturing
3.3.3 Distribution and Marketing & Sales
3.3.4 Post-Sales Services
3.4 Supply Chain Analysis
3.4.1 Prominent Companies
3.4.2 Small & Medium-Sized Enterprises
3.4.3 End-users
3.5 Ecosystem Analysis
3.6 Porter's Five Forces Analysis
3.6.1 Threat of New Entrants
3.6.2 Threat of Substitutes
3.6.3 Bargaining Power of Suppliers
3.6.4 Bargaining Power of Buyers
3.6.5 Intensity of Competitive Rivalry
3.7 Technology Analysis
3.7.1 Key Technologies
3.7.1.1 Portable Negative Pressure Wound Therapy (Npwt) Devices
3.7.2 Adjacent Technologies
3.7.2.1 Telemedicine for Wound Care
3.7.3 Complementary Technologies
3.7.3.1 Antimicrobial Wound Dressings
3.8 Patent Analysis
3.9 Key Conferences & Events, 2025
3.10 Trends/Disruptions Impacting Customers' Businesses
3.11 Impact of AI/Generative AI on Latam Advanced Wound Care Market
3.11.1 Introduction
3.11.2 Potential of AI in Advanced Wound Care
3.11.3 AI Use Cases
3.11.4 Future of Generative AI on Advanced Wound Care
4 Competitive Landscape
4.1 Overview
4.2 Key Player Strategies/Right to Win, 2024
4.2.1 Overview of Strategies Adopted by Key Players in Latam Advanced Wound Care Market
4.3 Revenue Analysis, 2021-2023
4.4 Market Share Analysis, 2024
4.5 Company Valuation and Financial Metrics
4.5.1 Company Valuation
4.5.2 Financial Metrics
4.6 Brand/Product Comparison
4.7 Company Evaluation Matrix: Key Players, 2024
4.7.1 Stars
4.7.2 Emerging Leaders
4.7.3 Pervasive Players
4.7.4 Participants
4.7.5 Company Footprint: Key Players, 2024
4.7.5.1 Company Footprint
4.7.5.2 Region Footprint
4.7.5.3 Product Footprint
4.7.5.4 Wound Type Footprint
4.7.5.5 End-user Footprint
4.8 Company Evaluation Matrix: Startups/SMEs, 2024
4.8.1 Progressive Companies
4.8.2 Responsive Companies
4.8.3 Dynamic Companies
4.8.4 Starting Blocks
4.8.5 Competitive Benchmarking: Startups/SMEs, 2024
4.8.5.1 Detailed List of Key Startups/SMEs
4.8.5.2 Competitive Benchmarking of Key Startups/SMEs
4.9 Competitive Scenario
4.9.1 Product Launches
4.9.2 Deals
4.9.3 Expansions
4.9.4 Other Developments
5 Company Profiles

• Solventum
• Molnlycke Ab
• Coloplast Group
• Smith+Nephew
• Convatec Group PLC
• Cardinal Health
• B. Braun SE
• Essity Aktiebolag
• Paul Hartmann AG
• Integra Lifesciences Corporation
• Mativ Holdings, Inc.
• Owens & Minor
• Avery Dennison Corporation
• Lohmann & Rauscher GmbH & Co. KG
• Medline Industries, LP
• Ferris Mfg. Corp.
• Triage Medtech
• Missner & Missner Ltda
• Deroyal Industries, Inc.
• Hollister Incorporated
• Winner Medical Co. Ltd.
• Urgo Medical
• Baihe Medical
• Cremer SA
• Advancis (UK)

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN27082025004107003653ID1109982241